Filter by:
Assessment of developments in use and access to care, marked by the health crisis linked to Covid-19.
For the second time since 1999, the EROPP general population survey provides an opportunity to review the perceptions and opinions of the French population on the drugs and public actions that affect them.
Although the forms and organisation of drug trafficking in France obviously have their own logic, they are also the consequence of a public policy and the ways in which the institutions responsible have implemented this policy.
Based on the findings of the 2017 Health Barometer Survey of Santé publique France (data processed by OFDT) which interviewed over 20 000 people aged 18 to 64 years, this issue of Tendances describes the changes in illicit drug use and offers an overview of cannabis supply modes.
Since 1999, the OFDT TREND scheme (Emerging Trends and New Drugs) has been monitoring current trends and those concerning emerging phenomena in the field of drugs.
Support centres for the reduction of drug-related harms (CAARUDs) are designed to carry out harm reduction measures aimed at psychoactive substance users. Tendances No 120 presents the 2015 results of a national survey of users attending these centres, named "ENa-CAARUD".
Since 1997 the OFDT has set up a perennial device based upon national general population surveys for observing drug-related uses, behaviours, and opinions.
The 2005 ESCAPAD survey (Survey on Health and Consumption on Call-up and Preparation for Defence Day) is the fifth nationwide survey of its kind to be organised.
This issue presents the first results of the French part of the ESPAD 2003 survey (European School Survey Project on Alcohol and Other Drugs) and concerns the use of psychoactive substances by young 12-18 year-old middle school and secondary school pupils.
A total of 32 new synthetic products were identified in France in 2021, with the emergence of synthetic opioids and the progression of synthetic cannabinoids. Among these 32 new identifications, 12 were made from samples collected for SINTES, the French National Detection System of Drugs and Toxic Substances.
The ESCAPAD survey, set up in 2000 by the OFDT with the logistical support of the Central bureau for the National Service (DCSN), contributes, every year, to reporting the trends in the use of psychoactive products among young French people.
Since 2000, once a year, the Health and drug use survey during call-up and preparation for defence (ESCAPAD) has questioned all the adolescents who attend their Call-up and preparation for defence day (JAPD) on the Wednesday and Saturday of a given week.
2015 was marked by record cocaine seizures - close on 11 tonnes - on French territory.
The public authorities and health and prevention activists are paying particular attention to the use of psychoactive substances in adolescents.
This issue of Tendances includes four articles. How many opiate users are there on high dosage buprenorphine (HDB)? Impact of substitution treatments: assessment of the last ten years. HDB misuse. Non-substitutive uses of high dosage buprenorphine in France.
The data presented in this issue of Tendances have been collected as part of the RECAP survey (Recueil commun sur les addictions et les prises en charges or Common data collection on addictions and treatments) carried out in 2005 at a national level for the first time.
An online survey among users of New Psychoactive Substances (NPS) was conducted in France, the Netherlands, Poland and the Czech Republic in 2014, in the context of the I-TREND project, supported by the European Commission.
The Covid-19 pandemic is the origin of a health crisis that has led to more than 848 000 deaths worldwide in seven months, including more than 30 000 in France.
Within the framework of the government's action plan against illicit drugs, tobacco and alcohol (2004-2008), a prevention programme against cannabis use has been up.
This issue offers, for the period July 2002 to the end of September 2003, an update on the observations made by the socio-health network.
